BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders

  Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to announce the results of its annual meeting of shareholders (the “Meeting”) held on December 15, 2022.

  December 16, 2022

   · 

  3 min read
• Biotechnology Market Size To Hold USD 1,683.52 Bn By 2030

  The global biotechnology market size was exhibited at USD 859.94 billion in 2022 and it is expected to hold around USD 1,683.52 billion by 2030, growing at a CAGR of 8.7% from 2022 to 2030.

  December 16, 2022

   · 

  8 min read
• Anti-Inflammatory Therapeutics Market Size To Hold USD 127.5 Bn By 2030

  The global anti-inflammatory therapeutics market size was exhibited at USD 102.37 billion in 2022 and it is expected to hold around USD 127.5 billion by 2030, growing at a CAGR of 4.5% from 2022 to 2030.

  December 16, 2022

   · 

  9 min read
• Genomic Biomarker Market Size To Hold USD 8.6 Bn By 2030

  The global genomic biomarker market size was exhibited at USD 4.84 billion in 2022 and it is expected to hold around USD 8.6 billion by 2030, growing at a CAGR of 7.46% from 2022 to 2030.

  December 16, 2022

   · 

  8 min read
• Namida Lab Announces Poster Presentation at the 2022 San Antonio Breast Cancer Symposium

  Namida Lab, the world leader in tear-based diagnostics, today announced that key research and developmental work on tear-based breast cancer biomarkers was presented at the San Antonio Breast Cancer Symposium (SABCS) on December 9, 2022, in San Antonio, Texas.

  December 16, 2022

   · 

  2 min read
• Business

  Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

  Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:00 A.M. Eastern time on Monday, February 6, 2023.

  December 16, 2022

   · 

  1 min read
• Biotech Bay

  Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences - December 16, 2022

  Agilent Technologies Inc. announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference and the J.P. Morgan Healthcare Conference.

  December 16, 2022

   · 

  1 min read
• FDA

  FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer

  The U.S. Food and Drug Administration approved Adstiladrin, a non-replicating adenoviral vector‑based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin -unresponsive non-muscle-invasive bladder cancer with carcinoma in situ with or without papillary tumors.

  December 16, 2022

   · 

  3 min read
• Policy

  On Target Laboratories Announces Expanded Indication of CYTALUX® (pafolacianine) injection for Detection of Lung Cancer During Surgery

  On Target Laboratories, Inc. announced that the U.S. Food and Drug Administration has approved an expanded indication for the use of CYTALUX in lung cancer.

  December 16, 2022

   · 

  7 min read
• Pharm Country

  The CHMP has Adopted a Negative Opinion for Omburtamab for the Treatment of CNS/LM Metastasis from Neuroblastoma in Europe

  Y-mAbs Therapeutics, Inc. announced that the European Committee for Medicinal Products for Human use has adopted a negative opinion recommending a refusal of the marketing authorization for omburtamab for the treatment of CNS/leptomeningeal metastasis from neuroblastoma in Europe.

  December 16, 2022

   · 

  4 min read